Arsanis, Inc. Uncategorized Contracts & Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
X4 Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (March 2022)
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Third Amendment to Option Agreement between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Modification Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Second Amendment to Option Agreement between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Modification Agreements
Arsanis, Inc.
Biotechnology
DE
2021
First Amendment to Option Agreement between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Modification Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Option Agreement between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP (March 18, 2021)
Arsanis, Inc.
Biotechnology
DE
2021
Description of Common Stock and Anti-Takeover Provisions under Restated Certificate and By-Laws
Arsanis, Inc.
Biotechnology
2021
Description of Common Stock and Registration Rights under Share Purchase Agreement with NEA
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
2020
Separation and Severance Agreement between Arsanis, Inc. and Rene Russo dated November 26, 2018
Severance Agreements
Arsanis, Inc.
Biotechnology
MA
2018
Support Agreement among X4 Pharmaceuticals, Inc., Arsanis, Inc., and Stockholder Regarding Merger
Voting Agreements
Arsanis, Inc.
Biotechnology
DE
2018
Support Agreement among X4 Pharmaceuticals, Inc., Arsanis, Inc., and Stockholder Regarding Merger
Voting Agreements
Arsanis, Inc.
Biotechnology
DE
2018
Grant Agreement Between Arsanis Inc. and Foundation for RSV Program Optimization
Funding Agreements
Arsanis, Inc.
Biotechnology
2018
Amended and Restated Grant Agreement (Amendment 2) between Arsanis, Inc. and Bill & Melinda Gates Foundation
Arsanis, Inc.
Biotechnology
GA
2018
Second Amended and Restated Stockholders’ Agreement among Arsanis, Inc., Investors, and Founders (2016, as amended 2017)
Shareholders Agreements
Arsanis, Inc.
Biotechnology
DE
2017
Amended and Restated Employment Letter Agreement between Arsanis, Inc. and Dr. Christopher Stevens
Employment Agreements
Arsanis, Inc.
Biotechnology
2017
Amended and Restated Employment Letter Agreement between Arsanis, Inc. and Michael Gray
Employment Agreements
Arsanis, Inc.
Biotechnology
2017
Amended and Restated Employment Letter Agreement between Arsanis, Inc. and Rene Russo (President & CEO)
Employment Agreements
Arsanis, Inc.
Biotechnology
2017
Second Amended and Restated Stockholders’ Agreement by and among Arsanis, Inc., Investors, and Founders (April 12, 2016)
Shareholders Agreements
Arsanis, Inc.
Biotechnology
DE
2017
Strategic Investment and Global Access Letter Agreement between Bill & Melinda Gates Foundation and Arsanis, Inc. (April 24, 2017)
Investment Agreements
Arsanis, Inc.
Biotechnology
DE
2017
Grant Agreement Between Bill & Melinda Gates Foundation and Arsanis, Inc. for RSV Monoclonal Antibody Development
Arsanis, Inc.
Biotechnology
GA
2017
Arsanis, Inc. Chief Medical Officer Employment Offer Letter with Christopher Stevens
Employment Agreements
Arsanis, Inc.
Biotechnology
2017
Arsanis, Inc. Offer Letter to Michael Gray for Chief Financial Officer and Chief Business Officer Position
Employment Agreements
Arsanis, Inc.
Biotechnology
2017
Arsanis, Inc. Confidential Offer Letter for Chief Development Officer René Russo
Employment Agreements
Arsanis, Inc.
Biotechnology
2017